Journal of Aesthetic & Reconstructive Surgery

Advertise

Journal of Aesthetic & Reconstructive Surgery specializes in digital advertising to help clients inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine.

If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains.

We maintain high quality and ethical standards of publication industry, which makes us unique and better than the rest. Our accomplished readers direct major research programs, spend millions on supplies and equipment, and recommend patient therapies. If you sell research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator, here is your opportunity to advertise in the website that can connect you to leading experts and science specialists across the Globe.

Teaser must be provided by the advertiser in jpeg or jpg format which must have a high resolution based on the site the customers select or we may provide guidance to design your ad in suitable form with an additional charge. The teaser must be free of copyright and must not have a copyright issue.

We can also support your events and conferences by providing you with high quality reprints of published articles that can add value to your event.

Google Analytics Metrics for the Journal of Aesthetic & Reconstructive Surgery

A statistical representation of global users for Journal of Aesthetic & Reconstructive Surgery (Source: Google Analytics)

• The visitor’s traffic is the benchmark for the success of any scientific journal and the Journal of Aesthetic & Reconstructive Surgery is constantly attracting viewers across the world.
  
• According to the Google Analytics, more than 241014 readers are visiting to our journal websites for submitting manuscripts, to browse the latest research published on diabetes and metabolism and to refer the published content for conceptualizing their research study, deriving research hypotheses, case reports and validating their contributions.
• Readers from the major countries including United States, Japan, United Kingdom, India, Egypt and Nigeria visit our journal domain to learn about the ongoing research activities in this field.

Analysis on global internet users of https://aesthetic-reconstructive-surgery.imedpub.com/ (By Google Analytics)

iMedPub LTD was established in the year 1994 and operates a journal portfolio focusing on biomedical, environment, finance and marketing subjects. The main aim is to publish original, peer-reviewed articles following internationally recognized standard editorial guidelines, publication ethics and production policies. Several authors affiliated to reputed organizations, institutions, government bodies have published their valuable contributions with iMedPub LTD.

This itself is the testimony to the trust and confidence gained by the publisher over several years of publishing history. The web metric has revealed that iMedPub LTD is highly popular among scientific associations, libraries and professional bodies. More than 2,147,577 users have accessed the publisher website with more than 6,486,1480 page views.

Web metrics of iMedPub LTD (By Google Analytics)

• Users : 2,147,577
• Page views : 6,486,148
• Downloads : 76

As per the latest available Google Stats, the number of web sessions was 2,882,056 with 2.25 percent rate of new sessions. Additionally several users are also revisiting the web site indicating their sustained interest to read and publish content with iMedPub LTD journal. Upon considering the stats for the linked resources of iMedPub LTD, the counts will be much higher.